Gijs Versteeg

Dr. Gijs Versteeg

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Journal of Molecular Biology
Verified
Journal Article
Closed access
RRRicardo Rajsbaum
Ricardo Rajsbaum
AGAdolfo Garcia-Sastre
Adolfo Garcia-Sastre
GVGijs Versteeg
Gijs Versteeg

1 February 2013 in Immunity
Verified
Journal Article
Closed access
GVGijs Versteeg
Gijs Versteeg
RRRicardo Rajsbaum
Ricardo Rajsbaum
MSMaria Teresa Sánchez-Aparicio
Maria Teresa Sánchez-Aparicio
AMAna M. Maestre
Ana M. Maestre
JVJulio Valdiviezo
Julio Valdiviezo
AGAdolfo Garcia-Sastre
Adolfo Garcia-Sastre

29 November 2012 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
RRRicardo Rajsbaum
Ricardo Rajsbaum
RARandy Albrecht
Randy Albrecht
MWMay K. Wang
May K. Wang
NMNatalya P. Maharaj
Natalya P. Maharaj
GVGijs Versteeg
Gijs Versteeg
MGMichaela U. Gack
Michaela U. Gack
Influenza A viruses can adapt to new host species, leading to the emergence of novel pathogenic strains. There is evidence that highly pathogenic viruses encode for non-structural 1 (NS1) proteins that are more efficient in suppressing the host immune response. The NS1 protein inhibits type-I interferon (IFN) production partly by blocking the TRIM25 ubiquitin E3 ligase-mediated Lys63-linked ubiquitination of the viral RNA sensor RIG-I, required for its optimal downstream signaling. In order to understand possible mechanisms of viral adaptation and host tropism, we examined the ability of NS1 encoded by human (Cal04), avian (HK156), swine (SwTx98) and mouse-adapted (PR8) influenza viruses to interact with TRIM25 orthologues from mammalian and avian species. Using co-immunoprecipitation assays we show that human TRIM25 binds to all tested NS1 proteins, whereas the chicken TRIM25 ortholog binds preferentially to the NS1 from the avian virus. Strikingly, none of the NS1 proteins were able to bind mouse TRIM25. Since NS1 can inhibit IFN production in mouse, we tested the impact of TRIM25 and NS1 on RIG-I ubiquitination in mouse cells. While NS1 efficiently suppressed human TRIM25-dependent ubiquitination of RIG-I 2CARD, NS1 inhibited the ubiquitination of full-length mouse RIG-I in a mouse TRIM25-independent manner. Therefore, we tested if the ubiquitin E3 ligase Riplet, which has also been shown to ubiquitinate RIG-I, interacts with NS1. We found that NS1 binds mouse Riplet and inhibits its activity to induce IFN-β in murine cells. Furthermore, NS1 proteins of human but not swine or avian viruses were able to interact with human Riplet, thereby suppressing RIG-I ubiquitination. In conclusion, our results indicate that influenza NS1 protein targets TRIM25 and Riplet ubiquitin E3 ligases in a species-specific manner for the inhibition of RIG-I ubiquitination and antiviral IFN production. Influenza viruses cause annual epidemics and occasionally, major global pandemics. To establish productive infection these viruses have mechanisms to evade host immune responses, including the type-I interferon (IFN) response. An important component of the IFN system is the helicase RIG-I that recognizes viral RNA, and is subsequently ubiquitinated by TRIM25 ubiquitin E3 ligase to induce downstream signaling resulting in IFN-α/β production. The NS1 protein of influenza A viruses binds to human TRIM25 and inhibits TRIM25-dependent RIG-I ubiquitination and downstream RIG-I signaling. An important unresolved question is how viruses can inhibit the RIG-I pathway when infecting new hosts. Here we show that while human TRIM25 is able to bind to different NS1 proteins, chicken TRIM25 binds preferentially to the NS1 from an avian virus. Strikingly, mouse TRIM25 was unable to bind NS1. We found that NS1 blocks RIG-I signaling in mouse and human cells by different mechanisms. While NS1 inhibits human TRIM25-mediated RIG-I ubiquitination, in mouse cells NS1 suppresses RIG-I signaling by binding to and inhibiting the ubiquitin E3 ligase Riplet. These results help understand the immune evasion strategies used by influenza virus in different species, and may partly explain the ability of this virus to adapt to different host species.

1 August 2010 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
GVGijs Versteeg
Gijs Versteeg
AGAdolfo Garcia-Sastre
Adolfo Garcia-Sastre

1 June 2014 in Immunity
Verified
Journal Article
Closed access
RRRicardo Rajsbaum
Ricardo Rajsbaum
GVGijs Versteeg
Gijs Versteeg
SSSonja Schmid
Sonja Schmid
AMAna M. Maestre
Ana M. Maestre
ABAlan Belicha-Villanueva
Alan Belicha-Villanueva
AGAdolfo Garcia-Sastre
Adolfo Garcia-Sastre

1 October 2014 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
GVGijs Versteeg
Gijs Versteeg
SBStefan Benke
Stefan Benke
AGAdolfo Garcia-Sastre
Adolfo Garcia-Sastre
RRRicardo Rajsbaum
Ricardo Rajsbaum